Exact Mass: 395.15213560000007
Exact Mass Matches: 395.15213560000007
Found 42 metabolites which its exact mass value is equals to given mass value 395.15213560000007,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Ethyl 2-hydroxy-3-(3-indolyl)propanoate glucoside
Ethyl 2-hydroxy-3-(3-indolyl)propanoate glucoside is found in alcoholic beverages. Ethyl 2-hydroxy-3-(3-indolyl)propanoate glucoside is isolated from grapes (Reisling wine Isolated from grapes (Reisling wine). Ethyl 2-hydroxy-3-(3-indolyl)propanoate glucoside is found in alcoholic beverages.
Cloricromen
C20H26ClNO5 (395.1499416000001)
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors
N-(2,5-Dimethoxybenzyl)-N-(5-fluoro-2-phenoxyphenyl)acetamide
C23H22FNO4 (395.15327840000003)
DAA1106 is a potent and selective ligand for peripheral benzodiazepine receptor (PBR), as a potent and selective agonist at the peripheral benzodiazepine receptor. Target:PBR in vitro: DAA1106 binding to PBR was significantly increased in widespread areas in MCI subjects when compared to healthy controls.[1] DAA-1106 is a drug which acts as a potent and selective agonist at the peripheral benzodiazepine receptor, also known as the mitochondrial 18 kDa translocator protein or TSPO, but with no affinity at the GABAA receptor. [2] in vivo: DAA-1106 has anxiolytic effects in animal studies. DAA-1106 has a sub-nanomolar binding affinity (Ki) of 0.28nM, and has been used extensively in its 3H or 11C radiolabelled form to map TSPO in the body and brain, which has proved especially helpful in monitoring the progress of neurodegenerative diseases such as Alzheimer's disease. [2]
Morniflumate
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent
Ethyl 2-hydroxy-3-(3-indolyl)propanoate glucoside
4-methylbenzenesulfonate,1,2,3,3-tetramethylbenzo[e]indol-3-ium
C23H25NO3S (395.15550600000006)
4-[((2R)-Hydroxy-3-phthalimido)propylamine]phenyl-3-morpholinone
C21H21N3O5 (395.14811360000004)
BENZYL 2-ACETAMIDO-2-DEOXY-3,6-DI-O-ACETYL-ALPHA-D-GLUCOPYRANOSIDE
n-benzoyl-dl-phenylalanine 2-naphthyl ester
C26H21NO3 (395.15213560000007)
n-benzoyl-dl-phenylalanine 2-naphthyl ester [for determination of chymotrypsin]
C26H21NO3 (395.15213560000007)
Orbifloxacin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic
2-benzyl-1-(2-hydroxyethyl)-3-[(2-methyl-1H-indol-3-yl)azo]-1H-pyrazolium chloride
C21H22ClN5O (395.15127920000003)
2-(2-ethylhexyl)-4,7-di-(thiophene-2-yl)-2,1,3-benzotriazole
(2E)-2-Methyl-4-(9H-purin-6-ylamino)-2-buten-1-yl beta-D-glucopyranosiduronic acid
Morniflumate
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent
Cloricromen
C20H26ClNO5 (395.1499416000001)
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors
beta-L-arabinofuranosyl-(1->2)-beta-L-arabinofuranosyl-hydroxyproline
C15H25NO11 (395.14275399999997)
(4S)-4-[(2S,3R,4S,5S)-3-[(2R,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxypyrrolidine-2-carboxylic acid
C15H25NO11 (395.14275399999997)
1-[2-[[(2-Chloroanilino)-oxomethyl]amino]-2-methyl-1-oxopropyl]-4-piperidinecarboxylic acid ethyl ester
C19H26ClN3O4 (395.16117460000004)
5-(2,4-Dimethoxyphenyl)-7-(3,4-dimethoxyphenyl)-1,7-dihydrotetrazolo[1,5-a]pyrimidine
C20H21N5O4 (395.15934660000005)
4-Morpholinecarboxylic acid [3-(6-amino-5-cyano-3-ethyl-2,4-dihydropyrano[2,3-c]pyrazol-4-yl)phenyl] ester
C20H21N5O4 (395.15934660000005)
1-(1,3-Benzodioxol-5-yl)-3-[4-(4-hydroxyphenyl)piperazin-1-yl]pyrrolidine-2,5-dione
C21H21N3O5 (395.14811360000004)
2-[(4E)-4-[(3-ethoxy-4-hydroxyphenyl)methylidene]-2,5-dioxoimidazolidin-1-yl]-N-(3-methylphenyl)acetamide
C21H21N3O5 (395.14811360000004)
3-Hydroxy-1-adamantanecarboxylic acid [2-[2-(difluoromethoxy)anilino]-2-oxoethyl] ester
1-[1-(4-Methoxyphenyl)-2,5-dimethyl-3-pyrrolyl]-2-[(6-methyl-2-nitro-3-pyridinyl)oxy]ethanone
C21H21N3O5 (395.14811360000004)
(1S,9R,10R,11R)-12-(cyclopropanecarbonyl)-10-(hydroxymethyl)-6-oxo-5-pyridin-4-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid
C21H21N3O5 (395.14811360000004)
(1R,9S,10S,11S)-12-(cyclopropanecarbonyl)-10-(hydroxymethyl)-6-oxo-5-pyridin-4-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid
C21H21N3O5 (395.14811360000004)
2-Me-alpha-D-Fucp4NAc-(1->4)-beta-D-GlcpA
C15H25NO11 (395.14275399999997)
An amino disaccharide consisting of beta-D-glucopyranuronic acid having a 4-acetamido-4,6-dideoxy-2-O-methyl-alpha-L-galactopyranosyl attached at the 4-position.
Ceranib1
C26H21NO3 (395.15213560000007)
Ceranib1 is a ceramidase inhibitor. Ceranib1 inhibits ceramidase activity toward an exogenous ceramide analog, induces the accumulation of multiple ceramide species, decreases levels of sphingosine and S1P. Ceranib1 inhibits the proliferation of ovarian cancer cells[1].
(4as,6s,7r,7as)-1-hydroxy-4-(methoxycarbonyl)-7-methyl-4ah,5h,6h,7h,7ah-cyclopenta[c]pyridin-6-yl 1-methyl-2,7-naphthyridine-4-carboxylate
C21H21N3O5 (395.14811360000004)
3-[2-(hydroxymethyl)-3-methoxyphenyl]-10-methyl-2-phenyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one
C26H21NO3 (395.15213560000007)
3-hydroxy-6-[2-(5-hydroxy-5-methylhexyl)-1,3-thiazol-4-yl]-4,5-dimethoxypyridine-2-carboximidic acid
C18H25N3O5S (395.15148400000004)
1-hydroxy-4-(methoxycarbonyl)-7-methyl-4ah,5h,6h,7h,7ah-cyclopenta[c]pyridin-6-yl 1-methyl-2,7-naphthyridine-4-carboxylate
C21H21N3O5 (395.14811360000004)